nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—ADRB2—autistic disorder	0.91	1	CbGaD
Salbutamol—Isoprenaline—MAPK1—autistic disorder	0.00149	0.131	CrCbGaD
Salbutamol—Pirbuterol—ADRB2—autistic disorder	0.00114	0.101	CrCbGaD
Salbutamol—Levobunolol—ADRB2—autistic disorder	0.00102	0.0896	CrCbGaD
Salbutamol—Phenylephrine—MAOA—autistic disorder	0.000949	0.0834	CrCbGaD
Salbutamol—Terbutaline—ADRB2—autistic disorder	0.000932	0.082	CrCbGaD
Salbutamol—Isoetarine—ADRB2—autistic disorder	0.000897	0.0789	CrCbGaD
Salbutamol—Carteolol—ADRB2—autistic disorder	0.000867	0.0762	CrCbGaD
Salbutamol—Salmeterol—ADRB2—autistic disorder	0.000793	0.0697	CrCbGaD
Salbutamol—Nadolol—ADRB2—autistic disorder	0.000772	0.0679	CrCbGaD
Salbutamol—Clenbuterol—ADRB2—autistic disorder	0.000745	0.0655	CrCbGaD
Salbutamol—Bupranolol—ADRB2—autistic disorder	0.000737	0.0648	CrCbGaD
Salbutamol—Isoprenaline—ADRB2—autistic disorder	0.000373	0.0328	CrCbGaD
Salbutamol—Norepinephrine—ADRB2—autistic disorder	0.000345	0.0303	CrCbGaD
Salbutamol—Epinephrine—ADRB2—autistic disorder	0.000313	0.0275	CrCbGaD
Salbutamol—ADRB2—GPCR downstream signaling—VIP—autistic disorder	8.99e-05	0.00115	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GRM5—autistic disorder	8.99e-05	0.00115	CbGpPWpGaD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	8.95e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OXTR—autistic disorder	8.9e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—SCT—autistic disorder	8.81e-05	0.00112	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OXTR—autistic disorder	8.71e-05	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AVPR1A—autistic disorder	8.64e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—SCT—autistic disorder	8.62e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRP2—autistic disorder	8.58e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—AVP—autistic disorder	8.54e-05	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AVPR1A—autistic disorder	8.45e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—GABBR1—autistic disorder	8.4e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—ADM—autistic disorder	8.4e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRP2—autistic disorder	8.4e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—AVP—autistic disorder	8.36e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—VIP—autistic disorder	8.34e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GRM5—autistic disorder	8.34e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR5A—autistic disorder	8.23e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GABBR1—autistic disorder	8.22e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—ADM—autistic disorder	8.22e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PDE4B—autistic disorder	8.19e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GRM5—autistic disorder	8.16e-05	0.00104	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—VIP—autistic disorder	8.16e-05	0.00104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OXTR—autistic disorder	8.08e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR5A—autistic disorder	8.05e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PDE4B—autistic disorder	8.01e-05	0.00102	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—SCT—autistic disorder	8e-05	0.00102	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OPRM1—autistic disorder	7.93e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OXTR—autistic disorder	7.91e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—SCT—autistic disorder	7.83e-05	0.000999	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OPRM1—autistic disorder	7.76e-05	0.00099	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—ADM—autistic disorder	7.63e-05	0.000974	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GABBR1—autistic disorder	7.63e-05	0.000974	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GABBR1—autistic disorder	7.47e-05	0.000953	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—ADM—autistic disorder	7.47e-05	0.000953	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	7.45e-05	0.000951	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PDE4B—autistic disorder	7.44e-05	0.000949	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	7.29e-05	0.000931	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PDE4B—autistic disorder	7.28e-05	0.000928	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	7.26e-05	0.000926	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OPRM1—autistic disorder	7.2e-05	0.000919	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—autistic disorder	7.11e-05	0.000907	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OPRM1—autistic disorder	7.05e-05	0.000899	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1B—autistic disorder	7.04e-05	0.000899	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OXT—autistic disorder	7.04e-05	0.000899	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GABBR2—autistic disorder	7e-05	0.000893	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	6.95e-05	0.000887	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	6.89e-05	0.000879	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	6.89e-05	0.000879	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	6.84e-05	0.000873	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD1—autistic disorder	6.55e-05	0.000836	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	6.41e-05	0.000818	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	6.41e-05	0.000817	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1B—autistic disorder	6.4e-05	0.000816	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OXT—autistic disorder	6.4e-05	0.000816	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD3—autistic disorder	6.34e-05	0.000809	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	6.33e-05	0.000807	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OXT—autistic disorder	6.26e-05	0.000798	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	6.26e-05	0.000798	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1D—autistic disorder	6.24e-05	0.000796	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL5—autistic disorder	6.21e-05	0.000792	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	6.2e-05	0.000792	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CALCA—autistic disorder	6.13e-05	0.000782	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	6.1e-05	0.000778	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	6.07e-05	0.000775	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRLR—autistic disorder	6e-05	0.000766	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	6e-05	0.000765	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—COMT—autistic disorder	5.96e-05	0.000761	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD1—autistic disorder	5.95e-05	0.000759	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GSTP1—autistic disorder	5.93e-05	0.000757	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOA—autistic disorder	5.92e-05	0.000755	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	5.88e-05	0.00075	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRLR—autistic disorder	5.87e-05	0.000749	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	5.85e-05	0.000747	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	5.82e-05	0.000742	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GRM8—autistic disorder	5.8e-05	0.00074	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD3—autistic disorder	5.76e-05	0.000735	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—POMC—autistic disorder	5.68e-05	0.000724	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GRM8—autistic disorder	5.67e-05	0.000724	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL5—autistic disorder	5.64e-05	0.000719	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	5.63e-05	0.000719	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—WNT2—autistic disorder	5.61e-05	0.000717	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	5.57e-05	0.000711	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—POMC—autistic disorder	5.55e-05	0.000709	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GHR—autistic disorder	5.53e-05	0.000706	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL5—autistic disorder	5.51e-05	0.000704	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—WNT2—autistic disorder	5.49e-05	0.000701	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GSTM1—autistic disorder	5.45e-05	0.000696	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	5.45e-05	0.000696	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	5.45e-05	0.000695	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GHR—autistic disorder	5.41e-05	0.00069	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	5.38e-05	0.000686	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	5.33e-05	0.00068	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	5.14e-05	0.000656	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	5.1e-05	0.000651	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACADSB—autistic disorder	5.1e-05	0.000651	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INPP1—autistic disorder	5.1e-05	0.000651	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	4.99e-05	0.000637	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GRM5—autistic disorder	4.93e-05	0.000629	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VIP—autistic disorder	4.93e-05	0.000629	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	4.83e-05	0.000616	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VIP—autistic disorder	4.82e-05	0.000615	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GRM5—autistic disorder	4.82e-05	0.000615	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.77e-05	0.000609	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.73e-05	0.000603	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.72e-05	0.000603	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.67e-05	0.000596	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.67e-05	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.62e-05	0.00059	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—BTD—autistic disorder	4.55e-05	0.00058	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.51e-05	0.000575	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.51e-05	0.000575	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.43e-05	0.000565	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.41e-05	0.000563	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.41e-05	0.000563	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.39e-05	0.000561	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.38e-05	0.000559	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.33e-05	0.000553	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.3e-05	0.000548	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.29e-05	0.000547	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.26e-05	0.000543	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	4.16e-05	0.000531	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	4.12e-05	0.000526	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	4.03e-05	0.000514	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	4.02e-05	0.000513	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	3.93e-05	0.000501	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GZMB—autistic disorder	3.89e-05	0.000497	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TDO2—autistic disorder	3.87e-05	0.000493	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—POMC—autistic disorder	3.85e-05	0.000492	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.81e-05	0.000486	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.78e-05	0.000482	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.78e-05	0.000482	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.7e-05	0.000472	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.7e-05	0.000472	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.65e-05	0.000465	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DHCR7—autistic disorder	3.64e-05	0.000464	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.57e-05	0.000455	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.52e-05	0.000449	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.51e-05	0.000448	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.51e-05	0.000448	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—EXT1—autistic disorder	3.45e-05	0.00044	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC6A8—autistic disorder	3.45e-05	0.00044	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.44e-05	0.00044	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.44e-05	0.000438	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.44e-05	0.000438	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.42e-05	0.000436	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.4e-05	0.000434	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.37e-05	0.00043	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.34e-05	0.000427	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.33e-05	0.000425	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.33e-05	0.000425	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.3e-05	0.000421	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.29e-05	0.00042	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DAO—autistic disorder	3.29e-05	0.00042	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.26e-05	0.000416	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.22e-05	0.000411	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.21e-05	0.000409	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.2e-05	0.000408	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UPB1—autistic disorder	3.15e-05	0.000402	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3.14e-05	0.0004	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	3.13e-05	0.000399	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	3.06e-05	0.000391	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	2.99e-05	0.000382	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM5—autistic disorder	2.93e-05	0.000374	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ASMT—autistic disorder	2.93e-05	0.000374	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—autistic disorder	2.91e-05	0.000372	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRL—autistic disorder	2.91e-05	0.000371	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.85e-05	0.000364	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.84e-05	0.000363	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.76e-05	0.000352	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.75e-05	0.000352	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.68e-05	0.000342	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.59e-05	0.00033	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.58e-05	0.000329	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.53e-05	0.000323	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.52e-05	0.000322	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.43e-05	0.000311	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADSL—autistic disorder	2.39e-05	0.000305	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.38e-05	0.000304	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.37e-05	0.000303	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.37e-05	0.000302	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—XDH—autistic disorder	2.34e-05	0.000299	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.32e-05	0.000296	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.32e-05	0.000296	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.31e-05	0.000295	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STX1A—autistic disorder	2.3e-05	0.000293	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NPAS2—autistic disorder	2.3e-05	0.000293	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.26e-05	0.000288	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TCN2—autistic disorder	2.22e-05	0.000283	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.15e-05	0.000275	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.15e-05	0.000275	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADA—autistic disorder	2.12e-05	0.00027	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.11e-05	0.000269	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.11e-05	0.000269	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TSC2—autistic disorder	2.05e-05	0.000261	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—autistic disorder	2e-05	0.000256	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—autistic disorder	2e-05	0.000256	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TSC2—autistic disorder	2e-05	0.000256	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—autistic disorder	1.96e-05	0.00025	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—autistic disorder	1.96e-05	0.00025	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—RORA—autistic disorder	1.93e-05	0.000247	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.89e-05	0.000241	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.85e-05	0.000236	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOB—autistic disorder	1.81e-05	0.000231	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APC—autistic disorder	1.81e-05	0.000231	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.81e-05	0.000231	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.79e-05	0.000228	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APC—autistic disorder	1.77e-05	0.000226	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.77e-05	0.000226	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.75e-05	0.000223	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.72e-05	0.00022	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.68e-05	0.000215	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPH2—autistic disorder	1.68e-05	0.000215	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DPYD—autistic disorder	1.66e-05	0.000211	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.66e-05	0.000211	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.65e-05	0.00021	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.62e-05	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.61e-05	0.000206	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.57e-05	0.000201	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.54e-05	0.000196	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.54e-05	0.000196	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DHFR—autistic disorder	1.4e-05	0.000179	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.32e-05	0.000169	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.29e-05	0.000165	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.27e-05	0.000162	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.27e-05	0.000162	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.24e-05	0.000159	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.24e-05	0.000158	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.2e-05	0.000153	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.17e-05	0.000149	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.1e-05	0.00014	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—autistic disorder	1.02e-05	0.00013	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTP1—autistic disorder	1.01e-05	0.00013	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOA—autistic disorder	1.01e-05	0.000129	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAT—autistic disorder	9.88e-06	0.000126	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	9.73e-06	0.000124	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	9.52e-06	0.000121	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—autistic disorder	9.33e-06	0.000119	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G4A—autistic disorder	9.33e-06	0.000119	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX1—autistic disorder	8.93e-06	0.000114	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—autistic disorder	8.24e-06	0.000105	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HRAS—autistic disorder	7.81e-06	9.97e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—autistic disorder	7.67e-06	9.79e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HRAS—autistic disorder	7.64e-06	9.75e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—autistic disorder	7.48e-06	9.54e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—autistic disorder	7.31e-06	9.33e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.92e-06	8.84e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—autistic disorder	6.59e-06	8.41e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—autistic disorder	5.26e-06	6.71e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTEN—autistic disorder	4.59e-06	5.85e-05	CbGpPWpGaD
